Home > Insider Trading > Filing (0001415889-25-009947)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1427925	Talphera Inc.	TLPH	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1700225	J. Vincent Angotti	C/O Talphera, Inc. 1850 Gateway Drive, Suite 175 San Mateo CA 94404	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-04-02	213,310	$0.59	403,769	No	4	P	Direct
Common Stock	Acquisiton	2025-04-02	61,000	$0.00	474,769	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2025-04-02	365,000	$0.00	365,000	$0.58

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
365,000		2035-04-01	No	4	A	Direct

Footnotes

The restricted stock units shall vest in three equal consecutive annual installments on April 2, 2026, April 2, 2027 and April 2, 2028.
Balance includes non-reportable acquisition of 10,000 shares of Common Stock through the Company's Employee Stock Purchase Plan.
On April 2, 2025, the reporting person was granted an option to purchase 365,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.